Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 6/20 | 0.68 |
| ▸ | MEN1 | O00255 | 2/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.66 |
| ▸ | TP53 | P04637 | 2/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.66 |
| ▸ | HTT | P42858 | 2/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.51 |
| ▸ | BCHE | P06276 | 1/20 | 0.51 |
| ▸ | ACHE | P22303 | 1/20 | 0.51 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27727042 | 1.00 | DNM1 (0.68) | DNM1MEN1KMT2ATP53SMN1; SMN2 | |
| SCHEMBL27727105 | 1.00 | DNM1 (0.68) | DNM1MEN1KMT2ATP53SMN1; SMN2 | |
| SCHEMBL27221211 | 1.00 | DNM1 (0.68) | DNM1MEN1KMT2ATP53SMN1; SMN2 | |
| SCHEMBL27221208 | 1.00 | DNM1 (0.68) | DNM1MEN1KMT2ATP53SMN1; SMN2 | |
| SCHEMBL25287115 | 1.00 | DNM1 (0.68) | DNM1MEN1KMT2ATP53SMN1; SMN2 | |
| SCHEMBL25285878 | 1.00 | DNM1 (0.68) | DNM1MEN1KMT2ATP53SMN1; SMN2 | |
| SCHEMBL27706358 | 1.00 | DNM1 (0.68) | DNM1MEN1KMT2ATP53SMN1; SMN2 | |
| SCHEMBL10544914 | 1.00 | DNM1 (0.68) | DNM1MEN1KMT2ATP53SMN1; SMN2 | |
| SCHEMBL6542825 | 1.00 | DNM1 (0.68) | DNM1MEN1KMT2ATP53SMN1; SMN2 | |
| SCHEMBL10703723 | 1.00 | DNM1 (0.68) | DNM1MEN1KMT2ATP53SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120040501-A | Double phosphonic acid double salt containing acryloyloxy and quaternary ammonium cations | 江苏海洋大学 | 2025-05-27 | — | — | CN | claimed |
| CN-120040500-A | Soluble unsaturated double quaternary ammonium bisphosphonate | 江苏海洋大学 | 2025-05-27 | — | — | CN | claimed |
| EP-2848336-B1 | METHOD FOR MANUFACTURING HOLLOW METAL NANOPARTICLES | LG CHEMICAL LTD (KR) | 2017-04-26 | — | — | EP | claimed |
| EP-1809279-B1 | PARTICULATE COMPOSITIONS OF TUBULIN INHIBITOR | BAXTER INT (US) | 2013-05-29 | — | — | EP | claimed |
| EP-1686962-B9 | NANOPARTICULATE COMPOSITIONS HAVING A PEPTIDE AS A SURFACE STABILIZER | ELAN PHARMA INT LTD (IE) | 2012-10-03 | — | — | EP | claimed |
| EP-1871345-B1 | NANOPARTICULATE ERLOTINIB FORMULATIONS | ELAN PHARMA INT LTD (IE) | 2012-08-01 | — | — | EP | claimed |
| EP-1585502-B9 | FAST-DISINTEGRATING SOLID DOSAGE FORMS BEING NOT FRIABLE AND COMPRISING PULLULAN | ELAN PHARMA INT LTD (IE) | 2012-05-09 | — | — | EP | claimed |
| CN-101365449-B | Nanoparticulate benzothiophene formulations | ELAN PHARMA INT LTD | 2011-11-09 | — | — | CN | claimed |
| EP-1553927-B9 | GEL-STABILIZED NANOPARTICULATE ACTIVE AGENT COMPOSITIONS | ELAN PHARMA INT LTD (IE) | 2011-09-21 | — | — | EP | claimed |
| EP-1585502-B1 | FAST-DISINTEGRATING SOLID DOSAGE FORMS BEING NOT FRIABLE AND COMPRISING PULLULAN | ELAN PHARMA INT LTD (IE) | 2011-06-29 | — | — | EP | claimed |
| CN-101232870-A | Nanoparticulate imatinib mesylate formulations | ELAN PHARMA INT LTD (IE) | 2008-07-30 | — | — | CN | claimed |
| CN-101189001-A | Aerosol and injectable formulations of nanoparticulate benzodiazepine | ELAN PHARMA INT LTD (IE) | 2008-05-28 | — | — | CN | claimed |
| EP-1658053-B1 | NOVEL COMPOSITIONS OF SILDENAFIL FREE BASE | ELAN PHARMA INT LTD (IE) | 2008-02-27 | — | — | EP | claimed |
| CN-101132768-A | Nanoparticulate tacrolimus formulations | ELAN PHARMA INT LTD (IE) | 2008-02-27 | — | — | CN | claimed |
| EP-1490025-B1 | NANOPARTICULATE COMPOSITIONS OF MAP KINASE INHIBITORS | ELAN PHARMA INT LTD (IE) | 2008-02-13 | — | — | EP | claimed |
| CN-101106972-A | Injectable nanoparticulate olanzapine formulation | ELAN PHARMA INT LTD (IE) | 2008-01-16 | — | — | CN | claimed |
| EP-1443912-B1 | COMPOSITIONS HAVING A COMBINATION OF IMMEDIATE RELEASE AND CONTROLLED RELEASE CHARACTERISTICS | ELAN PHARMA INT LTD (IE) | 2007-08-29 | — | — | EP | claimed |
| EP-1429731-B1 | NANOPARTICULATE INSULIN FORMULATIONS | ELAN PHARMA INT LTD (IE) | 2007-01-03 | — | — | EP | claimed |
| EP-1490030-B1 | NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS | ELAN PHARMA INT LTD (IE) | 2006-10-25 | — | — | EP | claimed |
| CN-1668281-A | Nanoparticulate fibrate formulations | ELAN PHARMA INT LTD (IE) | 2005-09-14 | — | — | CN | claimed |